Table 4. Bacterial antibiotic susceptibilities (%) for common first- and second-line therapies for treating children with SAM: results of a meta-analysis of 767 children from Uganda, Kenya, Turkey, Nigeria, Kenya and South Africa [30].
Antibiotic | Median | Interquartile range | Population-weighted mean (meta-analysis)* |
---|---|---|---|
Amoxicillin | 42 | 27–55 | 52.9 |
Co-trimoxazole | 22 | 17–23 | 35.4 |
Gentamicin | 80 | 77–85 | 72.8 |
Amoxicillin–gentamicin combination | 91.4 | 87–96 | 90.7 |
Chloramphenicol | 57.5 | 46–69 | 73.7 |
Ciprofloxacin | 93 | 82–93 | 90.0 |
Ceftriaxone | 84 | 80–94 | 89.3 |
Amoxicillin–clavulanate | 51 | 23–56 | 30.7 |
Mean susceptibility weighed proportionally (coefficient) to number of patients per study.